Clinical Trial Update: A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection [Phase 1, Phase 2]

View source ↗

Summary

A platform Phase 1/2 study evaluating investigational therapies for chronic hepatitis B infection has completed, with results posted on November 26, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Vir Biotechnology, Inc. | Conditions: Hepatitis B, Chronic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-26